Konturek P Ch, Brzozowski T, Konturek S J, Taut A, Pierzchalski P, Elia G, Pajdo R, Yagi S, Hahn E G
Department of Medicine I, University Erlangen-Nuremberg, Erlangen, Germany.
Regul Pept. 1998 Oct 16;77(1-3):95-103. doi: 10.1016/s0167-0115(98)00105-0.
Pancreatic secretory trypsin inhibitor (PSTI) is an inhibitor of serine-proteinases including pancreatic trypsin that prevents excessive digestion of the gastrointestinal mucus, but its role in the mechanism of mucosal defense has been little studied. This study was designed to determine the effect of base variant of human PSTI (R44S-PSTI) on gastric secretion, healing of gastric lesions induced by stress and the expression of PSTI during mucosal recovery from stress lesions. Recombinant R44S-PSTI was obtained using by site-directed mutagenesis due to replacement of arginine by serine that led to longer half life of this peptide than its natural form. Stress ulcerations were induced by exposure of rats to a standard 3.5 h of water immersion and restraint stress with or without pretreatment with vehicle or R44S-PSTI (0.1 mg/kg) applied s.c. 30 min before and immediately after the end of stress. Rats were then sacrificed immediately (time 0) and at 6 h or 12 h after the termination of stress. The gastric blood flow (GBF) was measured by H2-gas clearance technique at each time period and gastric mucosal samples were excised for assessment of PSTI immunohistochemical expression and PSTI messenger RNA by reverse transcriptase polymerase chain reaction (RT-PCR) and Southern hybridization. Stress produced numerous gastric lesions and decreased the GBF by about 30% as compared to the respective value in vehicle-treated non-stressed gastric mucosa. R44S-PSTI given s.c. in graded doses (0.01-1 mg/kg) inhibited dose-dependently gastric acid and pepsin outputs, in rats with gastric fistula and accelerated the healing of stress-induced gastric lesions significantly. The healing effects of R44S-PSTI (0.1 mg/kg s.c.) recorded at 6 h and 12 h after the end of stress were accompanied by a significant rise in the GBF. The expression of PSTI mRNA in the intact mucosa was weak, but following exposure to stress it was significantly augmented to reach the highest observed value at 6 h after the stress. We conclude that (1) base variant of human PSTI accelerates healing of stress-induced gastric lesions probably due to its antisecretory activity and enhancement of mucosal blood flow and (2) the expression of genes for PSTI plays an important role in the mechanism of mucosal recovery from gastric lesions induced by stress.
胰腺分泌型胰蛋白酶抑制剂(PSTI)是一种丝氨酸蛋白酶抑制剂,包括胰腺胰蛋白酶,可防止胃肠道黏液过度消化,但其在黏膜防御机制中的作用鲜有研究。本研究旨在确定人PSTI的碱基变体(R44S-PSTI)对胃分泌、应激诱导的胃损伤愈合以及应激损伤黏膜恢复过程中PSTI表达的影响。通过定点诱变获得重组R44S-PSTI,因为丝氨酸取代精氨酸导致该肽的半衰期比天然形式更长。通过将大鼠暴露于标准的3.5小时水浸和束缚应激来诱导应激性溃疡,在应激开始前30分钟和应激结束后立即皮下注射载体或R44S-PSTI(0.1毫克/千克)进行预处理或不进行预处理。然后在应激结束后立即(时间0)以及应激终止后6小时或12小时处死大鼠。在每个时间段通过氢气清除技术测量胃血流量(GBF),并切除胃黏膜样本,通过逆转录聚合酶链反应(RT-PCR)和Southern杂交评估PSTI免疫组化表达和PSTI信使核糖核酸。与载体处理的非应激胃黏膜中的相应值相比,应激产生了大量胃损伤并使GBF降低了约30%。以分级剂量(0.01 - 1毫克/千克)皮下注射R44S-PSTI可剂量依赖性地抑制胃瘘大鼠的胃酸和胃蛋白酶分泌,并显著加速应激诱导的胃损伤愈合。在应激结束后6小时和12小时记录的R44S-PSTI(0.1毫克/千克皮下注射)的愈合效果伴随着GBF的显著升高。完整黏膜中PSTI mRNA的表达较弱,但在暴露于应激后显著增强,在应激后6小时达到观察到的最高值。我们得出结论:(1)人PSTI的碱基变体可能因其抗分泌活性和黏膜血流增强而加速应激诱导的胃损伤愈合;(2)PSTI基因的表达在应激诱导的胃损伤黏膜恢复机制中起重要作用。